SARS-CoV-2 Molecular Diagnostics Development
The highly pathogenic nature and transmission dynamics of SARS-CoV-2 have necessitated the availability of rapid, robust detection methods to ensure that infected individuals are treated in a timely manner. For SARS-CoV-2 molecular diagnostics manufacturers moving from emergency use authorization (EUA) to 510(k) premarket submission to the US Food & Drug Administration (FDA), robust testing must be performed to demonstrate that the device is safe and effective as well as substantially equivalent to legally marketed devices. To support these validation studies, ATCC provides an extensive array of authenticated and clinically relevant materials for evaluating limit of detection, inclusivity, and cross-reactivity.
Develop your SARS-CoV-2 assayAssay development resources
Molecular standards
The extraction, preparation, and verification of nucleic acids can often require extensive amounts of time, labor, and expense. ATCC has addressed this issue by developing convenient, easy-to-use, genomic and synthetic molecular standards for quantitative nucleic acid amplification applications. These highly validated process controls remove the burden of culture work, nucleic acid extraction, and quantitation.
Find molecular standards
Purified viruses
Accurate and sensitive detection methods are critical for controlling the spread of highly infectious pathogens. However, the development and validation of these assays are limited by the availability of precisely quantified controls. To address this issue, ATCC has developed quantitative genomic and synthetic molecular standards representing clinically relevant strains.
Explore high-titer virusesDiscover how credible leads to incredible
ATCC Genome Portal
Enhanced Authentication Initiative
ATCC is not only enriching the characterization of our biological collections by using next-generation sequencing, we are also making those data available to everyone through the ATCC Genome Portal.
ATCC Genome Portal
The ATCC Genome Portal makes it easy to find the high-quality whole-genome sequencing data needed for your research. Using your ATCC login, you can easily search, download, and analyze hundreds of high quality genomes.
New products
SARS-CoV-2 Monoclonal Antibodies
Monoclonal antibodies prepared against the SARS-CoV-2 spike glycoprotein receptor binding domain and purified by protein G chromatography.
Explore now
Genomic RNA from SARS-CoV-2 Omicron Variant
Whole-genome sequenced preparation derived from strain USA/GA-EHC-2811C/2021.
Get it now
SARS-CoV-2 Omicron Variant
Heat-inactivated preparation of strain USA/GA-EHC-2811C/2021. This strain was isolated in December 2021 from a clinical specimen in Georgia, USA.
Order now
SARS-CoV-2 Delta Variant
Heat-inactivated preparation of strain USA/MD-HP05285/2021. This strain was isolated from a clinical specimen in Maryland.
Order now
HCM-BROD-0199-C71-B
Next-generation cancer model for glioblastoma. This model has applications in compound screening and basic research.
Order now
MDCK.STAT1 KO
For Influenza vaccine production, influenza propagation, and production of high-titer influenza stocks.
order today
Vero.STAT1 KO
For viral vaccine production including virus propagation, production of high-titer viral stocks, and rescue of clinical viral isolates.
buy today
THP-1 NF-κB-Luc2
A luciferase reporter cell line with applications in drug development and screening.
Discover more
HCM-CSHL-0085-C24-01A
Organoid model derived from the small intestine with applications in basic research and compound screening.
Get it now
ATCC (American Type Culture Collection) is a nonprofit, global biological resource center and standards organization and the leading developer and supplier of authenticated cells lines and microorganisms. We leverage our rich history and knowledge to provide the products, services, and resources scientists need to conduct critical life science research.
